{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:39:45Z","timestamp":1780922385713,"version":"3.54.1"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,8,15]]},"DOI":"10.2169\/internalmedicine.4828-24","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T17:12:39Z","timestamp":1739812359000},"page":"2466-2471","source":"Crossref","is-referenced-by-count":1,"title":["Post-Transplant Lymphoproliferative Disorder Which Developed 45 Years After Kidney Transplantation"],"prefix":"10.2169","volume":"64","author":[{"given":"Nobuaki","family":"Nishima","sequence":"first","affiliation":[{"name":"Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Hamasaki","sequence":"additional","affiliation":[{"name":"Department of Hemodialysis and Apheresis, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giyoung","family":"Kwoun","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Hirakawa","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Chiba","sequence":"additional","affiliation":[{"name":"Division of Hematology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Horiguchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Morton M, Coupes B, Roberts SA, et al. Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients. Transplantation 95: 470-478, 2013.","DOI":"10.1097\/TP.0b013e318276a237"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kato T, Yoshida T, Taniguchi A, et al. Incidence and mortality of post-transplant lymphoproliferative disorders after kidney transplantation: a real-world retrospective analysis in Japan. Int J Urol 29: 206-211, 2022.","DOI":"10.1111\/iju.14750"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Khedmat H, Taheri S. Very late onset lymphoproliferative disorders occurring over 10 years post-renal transplantation: PTLD. Int. Survey. Hematol Oncol Stem Cell Ther 4: 73-80, 2011.","DOI":"10.5144\/1658-3876.2011.73"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med 378: 549-562, 2018.","DOI":"10.1056\/NEJMra1702693"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Kempf C, Tinguely M, Rushing EJ. Posttransplant lymphoproliferative disorder of the central nervous system. Pathobiology 80: 310-318, 2013.","DOI":"10.1159\/000347225"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kotton CN, Fishman JA. Viral infection in the renal transplant recipient. J Am Soc Nephrol 16: 1758-1774, 2005.","DOI":"10.1681\/ASN.2004121113"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tiede C, Maecker-Kolhoff B, Klein C, et al. Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases. Transplantation 95: 479-488, 2013.","DOI":"10.1097\/TP.0b013e3182762e07"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gwon JG, Kim YH, Han DJ. Different causes of early and late onset post transplant lymphoproliferative disorder in kidney transplantation patients after 2000. Asian J Surg 42: 551-556, 2019.","DOI":"10.1016\/j.asjsur.2018.09.002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bishnoi R, Minish J, Franke AJ, et al. Single-institution retrospective analysis of prognostic factors influencing very late-onset post-transplant lymphoproliferative disorder. Cureus 12: e6912, 2020.","DOI":"10.7759\/cureus.6912"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sprangers B, Riella LV, Dierickx D. Posttransplant lymphoproliferative disorder following kidney transplantation: a review. Am J Kidney Dis 78: 272-281, 2021.","DOI":"10.1053\/j.ajkd.2021.01.015"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Caillard S, Porcher R, Provot F, et al. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. J Clin Oncol 31: 1302-1309, 2013.","DOI":"10.1200\/JCO.2012.43.2344"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Francis A, Johnson DW, Craig J, et al. Post-transplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipients. Kidney Int 94: 809-817, 2018.","DOI":"10.1016\/j.kint.2018.06.009"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Serre JE, Michonneau D, Bachy E, et al. Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival. Kidney Int 85: 182-190, 2014.","DOI":"10.1038\/ki.2013.253"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Holland E, Altshuler E, Franke AJ. Extremely delayed-onset post-transplant lymphoproliferative disorder in a renal transplant patient. BMJ Case Rep 15: 2022.","DOI":"10.1136\/bcr-2022-250625"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Pascual J. Post-transplant lymphoproliferative disorder - the potential of proliferation signal inhibitors. Nephrol Dial Transplant 22 (Suppl 1): i27-i35, 2007.","DOI":"10.1093\/ndt\/gfm088"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Pegoraro F, Favre C. Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation. Ann Hematol 100: 865-878, 2021.","DOI":"10.1007\/s00277-021-04433-y"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Depuydt P, Nollet J, Benoit D, et al. Fatal acute pulmonary injury associated with everolimus. Ann Pharmacother 46: e7, 2012.","DOI":"10.1345\/aph.1Q623"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Dejust S, Morland D, Bruna-Muraille C, et al. Everolimus-induced pulmonary toxicity: findings on <sup>18<\/sup>F-FDG PET\/CT imaging. Medicine (Baltimore) 97: e12518, 2018.","DOI":"10.1097\/MD.0000000000012518"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/16\/64_4828-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T03:43:23Z","timestamp":1755315803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/16\/64_4828-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":18,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4828-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"article-number":"4828-24"}}